ONYMED for nail disorders
Innovative long-acting regionally active delivery device system for common dermatologic nail diseases.
Product available for licensing out.
ONYMED is an innovative long acting technology platform designed to provide a safer and more efficient way to treat or prevent a wide range of nail disorders and diseases. The current marketed therapies for nail disease and nail-growth enhancement, such as nail lacquers and oral treatments have poor efficacy due to the challenge of delivering drug through the nail or to the site of disease. Oral drugs carry a risk of adverse effects.
ONYMED provides a convenient, continuous drug exposure at safe and effective levels, dramatically reducing the dose and the frequency of treatment.
Clinical Investigator studies have started. ASCIL Biopharm is in partnering discussion for further clinical development and commercialization.
Developed by Web4Bio